Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inHematology Frontier

2026 IFSC | Professor Naoki Hosen Explores Novel Targets for Cell Therapy in Hematologic Malignancies: Balancing Efficacy and Safety and Advancing from CAR-T to CAR-NK

Posted by By Ailiyaer Ainiwaer（Elyar Anwar） 2026.11.13Posted inHematology Frontier0 Shares
Home » 2026 IFSC | Professor Naoki Hosen Explores Novel Targets for Cell Therapy in Hematologic Malignancies: Balancing Efficacy and Safety and Advancing from CAR-T to CAR-NK
YouTube player
Views: 42

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2026.11.13
Ailiyaer Ainiwaer（Elyar Anwar）
View All Posts

Post navigation

Previous Post
ESMO LBA Insights | Professor Jong Chul Park Discusses the HexAgon-HN Study ESMO LBA Insights | Professor Jong Chul Park Discusses the HexAgon-HN Study
Next Post
ESMO LBA Insights | Pursuing Both Survival and Function: Professor Yue He Discusses the OPTIMAL Study ESMO LBA Insights | Pursuing Both Survival and Function: Professor Yue He Discusses the OPTIMAL Study
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
Paris, France
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied